Logi Analytics Acquired by Marlin Equity Partners
Oct 26, 2017 14:58 pm UTC| Business
MCLEAN, Va., Oct. 26, 2017 -- Logi Analytics, Inc. (“Logi”) is pleased to announce that it has been acquired by Marlin Equity Partners (“Marlin”), a global private equity firm with over $6.7 billion of capital under...
Sotherly Hotels Inc. Completes DoubleTree by Hilton(R) Conversion of Hollywood, Florida Hotel
Oct 26, 2017 14:52 pm UTC| Business
WILLIAMSBURG, Va., Oct. 26, 2017 -- Sotherly Hotels Inc. (NASDAQ:SOHO) (the “Company”) announced today that it has completed the conversion of the DoubleTree Resort by Hilton Hollywood Beach. The hotel underwent an...
Oct 26, 2017 14:50 pm UTC| Business
TORONTO, Oct. 26, 2017 -- Shawcor Ltd. (TSX:SCL) announced today that it expects to report its financial results for the period ended September 30th, 2017 on Friday, November 10th, 2017, after the close of trading on...
Shareholders Approve Union Bankshares Corporation Acquisition of Xenith Bankshares, Inc.
Oct 26, 2017 14:47 pm UTC| Business
Richmond, Va., Oct. 26, 2017 -- At separate special meetings today, shareholders of both Union Bankshares Corporation (“Union”) and Xenith Bankshares, Inc. (“Xenith”) approved the merger of Xenith with and into Union. ...
Rafael Acra, MD is Honored by the American Health Council for “Best in Medicine”
Oct 26, 2017 14:47 pm UTC| Business
NEW YORK, Oct. 26, 2017 -- The American Health Council is proud to honor Rafael Acra, MD as one of “America’s Best in Medicine.” Dr. Acra has spent the last decade of his nearly 30-year career as President and founder...
Oct 26, 2017 14:33 pm UTC| Business
New York, New York, Oct. 26, 2017 -- The 2017 World Tourism Awards will be presented to Charity Challenge and Micato Safaris-AmericaShare, on November 6, 2017, the opening day of World Travel Market London at the...
Crinetics Pharmaceuticals Initiates Phase 1 Study of Lead Candidate CRN00808 for Acromegaly
Oct 26, 2017 14:30 pm UTC| Business
SAN DIEGO, Oct. 26, 2017 -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced the initiation of a Phase 1, double-blind,...